{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:24:28Z","timestamp":1782563068669,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ygyno.2021.03.004","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:52:00Z","timestamp":1615423920000},"page":"727-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making"],"prefix":"10.1016","volume":"161","author":[{"given":"Cathalijne C.B.","family":"Post","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem M.","family":"Mens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie A.D.","family":"Haverkort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Koppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina M.","family":"J\u00fcrgenliemk-Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Snyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.A.","family":"Roeloffzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva E.","family":"Schaake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annerie","family":"Slot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja C.","family":"Stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannet C.","family":"Beukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetty A.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludy C.H.W.","family":"Lutgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans W.","family":"Nijman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis D.","family":"de Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith R.","family":"Kroep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Stiggelbout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carien L.","family":"Creutzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.03.004_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","author":"de Boer","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0010","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","article-title":"Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial","volume":"29","author":"Nout","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ijrobp.2015.08.023","article-title":"Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship: results from the randomized PORTEC-2 trial","volume":"93","author":"De Boer","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0020","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.ijrobp.2020.10.030","article-title":"Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial","volume":"109","author":"Post","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0025","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11606-008-0520-5","article-title":"Validation of screening questions for limited health literacy in a large VA outpatient population","volume":"23","author":"Chew","year":"2008","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0030","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/0272989X15581800","article-title":"Validation of a short, 3-item version of the subjective numeracy scale","volume":"35","author":"McNaughton","year":"2015","journal-title":"Med. Decis. Mak."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0035","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1200\/JCO.2001.19.1.220","article-title":"Patient preference for cancer therapy: an overview of measurement approaches","volume":"19","author":"Stiggelbout","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0040","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/bjc.2016.323","article-title":"Patients\u2019 and clinicians\u2019 preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial","volume":"115","author":"On behalf of the ANZGOG and PORTEC Group","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.03.004_bb0045","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/bjc.2014.322","article-title":"Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians","volume":"111","author":"Kunneman","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.03.004_bb0050","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ctrv.2014.06.007","article-title":"Patients\u2019 preferences for surgical and adjuvant systemic treatment in early breast cancer: a systematic review","volume":"40","author":"Hamelinck","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0055","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1054\/bjoc.2001.1836","article-title":"Patients\u2019 preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?","volume":"84","author":"Jansen","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.03.004_bb0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/02729890122062596","article-title":"Stability of patients\u2019 preferences for chemotherapy: the impact of experience","volume":"21","author":"Jansen","year":"2001","journal-title":"Med. Decis. Mak."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0065","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1001\/jama.283.24.3217","article-title":"Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer","volume":"283","author":"Fowler","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2021.03.004_bb0070","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1023\/A:1008379628579","article-title":"Adjuvant chemotherapy in node negative breast cancer: patterns of use and oncologists\u2019 preferences","volume":"11","author":"Stiggelbout","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1245\/s10434-019-07963-y","article-title":"Preferences for immunotherapy in melanoma: a systematic review","volume":"27","author":"Livingstone","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0080","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s12094-019-02216-6","article-title":"Increased survival time or better quality of life? Trade-off between benefits and adverse events in the systemic treatment of cancer","volume":"22","author":"Valenti","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0085","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1038\/sj.bjc.6601445","article-title":"Palliative chemotherapy or best supportive care? A prospective study explaining patients\u2019 treatment preference and choice","volume":"89","author":"Koedoot","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.03.004_bb0090","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/IGC.0000000000001204","article-title":"Recurrent Cancer is associated with dissatisfaction with care-a longitudinal analysis among ovarian and endometrial cancer patients","volume":"28","author":"de Rooij","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.03.004_bb0095","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1200\/JCO.2006.05.9592","article-title":"Do patients with localized prostate cancer treatment really want more aggressive treatment?","volume":"24","author":"van Tol-Geerdink","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0100","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1200\/JCO.2006.07.4955","article-title":"Doctors\u2019 and patients\u2019 preferences for participation and treatment in curative prostate cancer radiotherapy","volume":"25","author":"Stalmeier","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0105","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/0272989X0202200314","article-title":"The role of physicians\u2019 recommendations in medical treatment decisions","volume":"22","author":"Gurmankin","year":"2016","journal-title":"Med. Decis. Mak."},{"key":"10.1016\/j.ygyno.2021.03.004_bb0110","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","author":"Leon-Castillo","year":"2020","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821001980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821001980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:47:59Z","timestamp":1715820479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821001980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0090825821001980"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.03.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}